Evidence map›Paper›PMID 29719235›Full record

ArticleCell metabolism2018

Glucose Homeostasis Is Important for Immune Cell Viability during Candida Challenge and Host Survival of Systemic Fungal Infection.

Timothy M Tucey, Jiyoti Verma, Paul F Harrison, Sarah L Snelgrove, Tricia L Lo, Allison K Scherer, Adele A Barugahare, David R Powell, Robert T Wheeler, Michael J Hickey and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell metabolism, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 137 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
137citing papers in PubMed, 1 pooled it
14.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

137 citing papers in PubMed, 1 synthesis or guideline pooled it, 213 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Response ofmSphere · 2026
    Article
  16. The pathogenicity and future treatment strategies ofFrontiers in cellular and infection microbiology · 2026
    Review
  17. Article
  18. Review
  19. Synergistic interactions betweenProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  20. mSphere · 2025
    Article

77 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Timothy M TuceyInfection and Immunity Program and the Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton 3800, VIC, Australia.
Jiyoti VermaInfection and Immunity Program and the Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton 3800, VIC, Australia.
Paul F HarrisonBioinformatics Platform, Monash University, Clayton 3800, VIC, Australia.
Sarah L SnelgroveCentre for Inflammatory Diseases, Monash University Department of Medicine, Monash Medical Centre, Clayton 3168, VIC, Australia.
Tricia L LoInfection and Immunity Program and the Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton 3800, VIC, Australia.
Allison K SchererDepartment of Molecular & Biomedical Sciences, University of Maine, Orono, ME, USA.
Adele A BarugahareBioinformatics Platform, Monash University, Clayton 3800, VIC, Australia.
David R PowellBioinformatics Platform, Monash University, Clayton 3800, VIC, Australia.
Robert T WheelerDepartment of Molecular & Biomedical Sciences, University of Maine, Orono, ME, USA.
Michael J HickeyCentre for Inflammatory Diseases, Monash University Department of Medicine, Monash Medical Centre, Clayton 3168, VIC, Australia.
Traude H BeilharzDevelopment and Stem Cells Program and the Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton 3800, VIC, Australia.
Thomas NadererInfection and Immunity Program and the Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton 3800, VIC, Australia. Electronic address: thomas.naderer@monash.edu.
Ana TravenInfection and Immunity Program and the Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton 3800, VIC, Australia. Electronic address: ana.traven@monash.edu.
Australian Regenerative Medicine Institute · AUMonash University · AUDiscovery Institute · USMonash Medical Centre · AUUniversity of Maine · US

Funding

Genetics and visualization of innate host response to C. albicans infection in viR15AI094406 · NIAID · UNIVERSITY OF MAINE ORONO · PI WHEELER, ROBERT T. · 2012 to 2012
$422k
Intravital study of innate immunity to mucosal candidiasisR15AI133415 · NIAID · UNIVERSITY OF MAINE ORONO · PI WHEELER, ROBERT T. · 2018 to 2018
$415k
NIAID NIH HHS R15 AI094406NIAID NIH HHS R15 AI133415
6 · The paper itself

Abstract

To fight infections, macrophages undergo a metabolic shift whereby increased glycolysis fuels antimicrobial inflammation and killing of pathogens. Here we demonstrate that the pathogen Candida albicans turns this metabolic reprogramming into an Achilles' heel for macrophages. During Candida-macrophage interactions intertwined metabolic shifts occur, with concomitant upregulation of glycolysis in both host and pathogen setting up glucose competition. Candida thrives on multiple carbon sources, but infected macrophages are metabolically trapped in glycolysis and depend on glucose for viability: Candida exploits this limitation by depleting glucose, triggering rapid macrophage death. Using pharmacological or genetic means to modulate glucose metabolism of host and/or pathogen, we show that Candida infection perturbs host glucose homeostasis in the murine candidemia model and demonstrate that glucose supplementation improves host outcomes. Our results support the importance of maintaining glucose homeostasis for immune cell survival during Candida challenge and for host survival in systemic infection.

Indexed as

Candida albicansGlycolysisAnimalsCandidemiaCell SurvivalDisease Models, AnimalHost-Pathogen InteractionsMacrophagesMiceMice, Inbred C57BLCandida albicansfungal infectionGAL4glucose homeostasisglycolysisimmunometabolismmacrophageTYE7Warburg effect

Identifiers

PMID29719235
PMCPMC6709535
OpenAlexW2800526695

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.